Retinal migraine reappraised

Cephalalgia

Volumn 26, Issue 11, 2006, Pages 1275-1286

  Grosberg, B M ^a,b   Solomon, S ^b   Friedman, D I ^c   Lipton, R B ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Headache classification; Migraine; Ocular migraine; Retinal migraine

Indexed keywords

ACETYLSALICYLIC ACID; AMYL NITRATE; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; CORTICOSTEROID; DEXAMETHASONE; DIPHENHYDRAMINE; FLUNARIZINE; GLYCERYL TRINITRATE; ISOPRENALINE; MAGNESIUM; METOPROLOL; NORTRIPTYLINE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; RIBOFLAVIN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VASODILATOR AGENT; VERAPAMIL;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; ENTERIC COATED TABLET; FATIGUE; FEMALE; HEADACHE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LABORATORY TEST; MALE; MIGRAINE; MIGRAINE WITH AURA; NEURORADIOLOGY; OPHTHALMOSCOPY; PROGNOSIS; RECURRENT DISEASE; RETINA DISEASE; REVIEW; SCHOOL CHILD; SIDE EFFECT; VISUAL IMPAIRMENT; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; AMAUROSIS FUGAX; BLINDNESS; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; RETINAL DISEASES;

EID: 33750377155     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01206.x     Document Type: Review

References (47)

1. Galezowski X. Ophthalmic megrim: an affection of the vasomotor nerves of the retina and retinal centre which may end in a thrombosis. Lancet 1882; 1:176-9.
2. Headache Classification Subcommittee of the International Headache Society. Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgias and Facial Pain, 2nd edition. Cephalalgia 2004; (Suppl. 1):1-160.
3. Connor RCR. Complicated migraine: a study of permanent neurological and visual defects caused by migraine. Lancet 1962; 2:1072-5.
4. Coppeto JR, Lessell S, Sciarra R, Bear L. Vascular retinopathy in migraine. Neurology 1986; 36:267-70.
5. Corbett JJ. Neuro-ophthalmic complications of migraine and cluster headaches. Neurologic Clinics 1983; 1:973-95.
6. Dunning HS. Intracranial and extracranial vascular accidents in migraine. Arch Neurol Psychiatry 1942; 48:396-406.
7. Fisher CM. Transient monocular blindness associated with hemiplegia. Arch Ophthalmol 1952; 47:167-203.
8. Fisher CM. Cerebral ischemia - less familiar types. Clin Neurosurg 1970; 18:267-335.
9. Fujino T, Akiya S, Takagi S, Shiga H. Amaurosis fugax for a long duration. J Clin Neuro-Ophthalmol 1983; 3:9-12.
10. Gee JR. Resolution of symptoms with divalproex sodium in retinal migraine. Headache 2004; 44:508-9 [Abstract].
11. Grosberg BM, Solmon S. Retinal migraine: two case of prolonged but reversible monocular visual defects. Cephalalgia 2006; 26:754-7.
12. Guidetti V, Tagliente F, Galli F. An adolescent with headache. In: Purdy RA, Rapoport AM, Sheftell FD, Tepper SJ editors. Advanced therapy of headache. New York: BC Decker Inc. 2005.
13. Hachinski VC, Porchawka J, Steele JC. Visual symptoms in the migraine syndrome. Neurology 1973; 23:570-9.
14. Inan LE, Uysal H, Ergun U, Yurdakul M, Karagoz H. Complicated retinal migraine. Headache 1994; 34:50-2.
15. James CB, Buckley SA, Cock S, Elston JS. Retinal migraine. Lancet 1993; 342:690.
16. Joffe SN. Retinal blood vessel diameter during migraine. Eye, Ear, Nose Throat Monthly 1972; 52:338-42.
17. Katz B. Migrainous central retinal artery occlusion. J Clin Neuro-Ophthalmol 1986; 6:69-71.
18. Kupersmith MJ, Warren FA, Hass WK. The non-benign aspects of migraine. Neuro-Ophthalmology 1987; 7:1-10.
19. Kupersmith MJ, Hass WK, Chase NE. Isoproterenol treatment of visual symptoms in migraine. Stroke 1979; 10:299-305.
20. Lee AG, Brazis PW, Miller NR. Posterior ischemic optic neuropathy associated with migraine. Headache 1996; 36:506-9.
21. Lewinshtein D, Shevell MI, Rothner AD. Familial retinal migraines. Pediatric Neurol 2004; 30:356-7.
22. Poole CJM, Russell RWR, Harrison P, Savidge GF. Amaurosis fugax under the age of 40 years. J Neurol, Neurosurg, Psychiatry 1987; 50:81-4.
23. Silberberg DH, Laties AM. Occlusive migraine. Trans Pa Acad Ophthalmol Otolaryngol 1974; 27:34-8.
24. Spierings EL. Flurries of migraine (with) aura and migraine aura status. Headache 2002; 42:326-7.
25. Sullivan-Mee M, Bowman B. Migraine-related visual field loss with prolonged recovery. J Am Optometric Assoc 1997; 68:377-88.
26. Grosberg BM, Solomon S, Bigal ME, Lipton RB. Is irreversible visual loss part of the retinal migraine spectrum? Neurology 2005; 64 (Suppl. 1):A221 [Abstract].
27. Grosberg BM, Solomon S, Lipton RB. Retinal migraine. Current Pain Headache Reports 2005; 9:268-71.
28. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41:646-57.
29. Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1993; 34:1111-20.
30. Kline LB, Kelly CL. Ocular migraine in a patient with cluster headaches. Headache 1980; 20:253-7.
31. Ammache Z, Graber M, Davis P. Idiopathic stabbing headache associated with monocular visual loss. Arch Neurol 2000; 57:745-6.
32. Ravaglia S, Costa A, Santorelli FM, Nappi G, Moglia A. Retinal migraine as unusual feature of cerebral autosomal dominant arteriopathy with subcortical infarcts with leukoencephalopathy (CADASIL). Cephalalgia 2004; 24:74-7.
33. Evans RW, Daroff RB. Monocular visual aura with headache: retinal migraine? Headache 2000; 40:603-4.
34. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119:355-61.
35. Russell MB, Iversen HK, Olesen J. Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia 1994; 14:107-17.
36. Lewis RA, Vijayan N, Watson C, Keltner J, Johnson CA. Visual field loss in migraine. Ophthalmology 1989; 96:321-6.
37. Drummond PD, Anderson M. Visual field loss after attacks of migraine with aura. Cephalalgia 1992; 12:349-52.
38. McKendrick AM, Badcock DR. An analysis of the factors associated with visual field deficits measured with flickering stimuli in-between migraine. Cephalalgia 2004; 24:389-97.
39. McColl SL, Wilkinson F. Migraineurs show visual field defects on motion coherence perimetry during the interictal period. Cephalalgia 2001; 21:391.
40. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual dysfunction between migraine events. Invest Ophthalmol Visual Sci 2001; 42:626-33.
41. Maggioni F, Dainese F, Mainardi F, Lisotto C, Zanchin G. Intermittent angle-closure glaucoma in the presence of a white eye, posing as retinal migraine. Cephalalgia 2005; 25:622-6.
42. Van Harreveld A. Two mechanisms for spreading depression in the chicken retina. J Neurobiol 1978; 9:419-31.
43. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retinal Eye Res 2001; 20:319-49.
44. Solomon S, Lipton RB, Harris PY. Arterial stenosis in migraine: spasm or arteriopathy? Headache 1990; 30:52-61.
45. Winterkorn JS, Kupersmith MJ, Wirtschafter JD, Forman S. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med 1993; 329:396-9.
46. Burger SK, Saul RF, Selhorst JB, Thurston SE. Transient monocular blindness caused by vasospasm. N Engl J Med 1991; 325:870-3.
47. O'Connor PS, Tredici T. Acephalgic migraine: fifteen years experience. Ophthalmology 1981; 88:999-1002.